LECTRUM

This brand name is authorized in Brazil, Ecuador

Active ingredients

The drug LECTRUM contains one active pharmaceutical ingredient (API):

1 Leuprorelin
UNII 37JNS02E7V - LEUPROLIDE ACETATE

Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis.

Read about Leuprorelin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LECTRUM Powder for suspension for injection Marketing Authorisation Holder MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02AE02 Leuprorelin L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 511513501158415, 511513502154413
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 392-MEE-0714, H-M48-10-02, H-M49-10-02

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.